Brief: Aziyo Biologics Reports First Quarter Results
May 10 (Reuters) - Aziyo Biologics Inc AZYO.O :
* AZIYO BIOLOGICS REPORTS HIGHEST SALES AND GROSS PROFIT IN
COMPANY HISTORY
* AZIYO BIOLOGICS INC Q1 SALES ROSE 14 PERCENT TO $13.1
MILLION
* AZIYO BIOLOGICS INC - NET LOSS WAS $8.0 MILLION IN Q1 OF
2023
Source text for Eikon: ID:nGNX22fxHc
Further company coverage: AZYO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elutia
See all newsBrief: Elutia Receives $8 Million Payment From Boston Scientific Company Now Fully Funded Into 2029
Elutia Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Elutia Secures $15 Million Loan Financing From Avenue Capital Group
Elutia's Q2 revenue falls on SimpliDerm production disruption
Elutia Inc expected to post a loss of 15 cents a share - Earnings Preview